# Ciprofloxacin

NDC: 70518-4133
Generic name: Ciprofolxacin
Labeler / Manufacturer: REMEDYREPACK INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240703

FDA application: ANDA208921

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70518-4133"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70518-4133
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4edc4fda-7834-46cc-a0ed-22f117e6e10b